Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,056 | $1,776 | $2,482 | $2,259 |
| % Growth | 15.8% | -28.4% | 9.9% | – |
| Cost of Goods Sold | $658 | $651 | $643 | $684 |
| Gross Profit | $1,398 | $1,125 | $1,839 | $1,575 |
| % Margin | 68% | 63.3% | 74.1% | 69.7% |
| R&D Expenses | $292 | $217 | $231 | $207 |
| G&A Expenses | $1,092 | $1,081 | $1,560 | $1,585 |
| SG&A Expenses | $1,608 | $1,766 | $2,587 | $2,542 |
| Sales & Mktg Exp. | $516 | $685 | $1,027 | $957 |
| Other Operating Expenses | $1,084 | $194 | $0 | $57 |
| Operating Expenses | $2,984 | $2,177 | $2,818 | $2,437 |
| Operating Income | -$1,586 | -$1,052 | -$947 | -$805 |
| % Margin | -77.1% | -59.2% | -38.2% | -35.6% |
| Other Income/Exp. Net | -$211 | -$230 | -$199 | -$173 |
| Pre-Tax Income | -$1,797 | -$1,282 | -$1,146 | -$978 |
| Tax Expense | $0 | $0 | -$1 | -$12 |
| Net Income | -$1,797 | -$1,282 | -$1,145 | -$966 |
| % Margin | -87.4% | -72.2% | -46.1% | -42.8% |
| EPS | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | 18.2% | 35.3% | 0% | – |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 1,895,570 | 1,181,567 | 685,491 | 580,712 |
| Weighted Avg Shares Out Dil | 1,893,732 | 1,181,215 | 685,491 | 580,712 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $230 | $199 | $173 |
| Depreciation & Amortization | $23 | $133 | $128 | $114 |
| EBITDA | -$807 | -$919 | -$819 | -$691 |
| % Margin | -39.3% | -51.7% | -33% | -30.6% |